<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "vinBLAStine inj VIAL">
<dose><value>3</value>
<value>2</value>
<value>0.15</value>
<value>4</value>
<value>0.11</value>
<value>6</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>vinBLAStine inj VIAL</value>
</drugname><strength><value>1 mg/mL</value>
</strength><frequency><value>WEEKLY</value>
<value>ONCE</value>
<value>DAILY</value>
</frequency><instruction><value>for 3 doses (Day 2, 15 &amp; 22). Administer dose over 10 minutes diluted in 50 mL 0.9% sodium chloride.</value>
<value>Administer dose over 10 minutes diluted in 50 mL 0.9% sodium chloride.</value>
<value>Administer undiluted by direct injection.</value>
<value>for 3 days. Administer dose over 10 minutes diluted in 50 mL 0.9% sodium chloride.</value>
<value>for 2 doses (DAY 1 &amp; 8). Administer over 10 minutes diluted in 50 mL 0.9% sodium chloride.</value>
<value>for 2 doses. (DAY 1 &amp; 2). Administer over 10 minutes diluted in 50 mL 0.9% sodium chloride.</value>
</instruction><volume><value>10 mL</value>
</volume><units><value>mg/m2</value>
<value>mg/kg</value>
<value>mg/kg/day</value>
</units><additionalnotes><value>Bladder Cancer. Recommend dosing at 66% of usual dose IF: ANC is less than 1.5 X 109/L and greater than or equal to 1 X 109/L, If ANC is less than 1 X 109/L; Delay chemotherapy for 1 week on DAY 2 or omit dose if on DAY 15 or 22. If platelets less than 100 X 109/L: Contact prescriber. Suggested dose adjustment if bilirubin 25 to 50 umol/L: 50% dose, if bilirubin greater than 50 umol/L: 25% dose.</value>
<value>Bladder Cancer. Recommend dosing at 66% of usual dose IF: ANC is less than 1.5 X 109/L and greater than or equal to 1 X 109/L, If ANC is less than 1 X 109/L; Delay chemotherapy for 1 week on DAY 2 or omit dose if on DAY 15 or 22. If platelets less than 100 X 109/L: Contact prescriber.</value>
<value>Bladder Cancer. If ANC is less than 1.5 X 109/L or Platelets are less than 100 X 109/L: HOLD chemotherapy and contact prescriber. Contact prescriber if hepatic impairment present.</value>
<value>Bladder Cancer. If ANC is less than 1.5 X 109/L or Platelets are less than 100 X 109/L: Delay one week. Contact prescriber if hepatic impairment present. It is strongly suggested vinBLAStine be administered via a minibag to prevent inadvertent intrathecal administration.</value>
<value>Ca Testes. Suggested dose adjustment if bilirubin 25 to 50 umol/L: 50% dose, if bilirubin greater than 50 umol/L: 25% dose.</value>
<value>Ca Testes, Germ Cell Cancer. Suggested dose adjustment if bilirubin 25 to 50 umol/L: 50% dose, if bilirubin greater than 50 umol/L: 25% dose.</value>
<value>Bladder Cancer. If ANC is less than 1.5 X 109/L or Platelets are less than 100 X 109/L: Delay one week. Contact prescriber if hepatic impairment present.</value>
<value>Germ Cell Cancer. Suggested dose adjustment if bilirubin 25 to 50 umol/L: 50% dose, if bilirubin greater than 50 umol/L: 25% dose.</value>
<value>Hodgkin&amp;apos;s Lymphoma. Suggested dose adjustment if bilirubin 25 to 50 umol/L: 50% dose, if bilirubin greater than 50 umol/L: 25% dose.</value>
<value>Hodgkin&amp;apos;s Lymphoma. Maximum single dose: 10 mg. Suggested dose adjustment if bilirubin 25 to 50 umol/L: 50% dose, if bilirubin greater than 50 umol/L: 25% dose.</value>
</additionalnotes><population><value>ADULT</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3459</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose><value>YES</value>
</maximumprndose></drug>